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Abstract: Reperfusion injury after extended ischemia accounts for approximately 50% of myocardial
infarct size, and there is no standard therapy. HDAC inhibition reduces infarct size and enhances
cardiomyocyte autophagy and PGC1α-mediated mitochondrial biogenesis when administered at the
time of reperfusion. Furthermore, a specific autophagy-inducing peptide, Tat-Beclin 1 (TB), reduces
infarct size when administered at the time of reperfusion. However, since SAHA affects multiple
pathways in addition to inducing autophagy, whether autophagic flux induced by TB maintains
mitochondrial homeostasis during ischemia/reperfusion (I/R) injury is unknown. We tested whether the
augmentation of autophagic flux by TB has cardioprotection by preserving mitochondrial
homeostasis both in vitro and in vivo. Wild-type mice were randomized into two groups: Tat-Scrambled
(TS) peptide as the control and TB as the experimental group. Mice were subjected to I/R surgery
(45 min coronary ligation, 24 h reperfusion). Autophagic flux, mitochondrial DNA (mtDNA),
mitochondrial morphology, and mitochondrial dynamic genes were assayed. Cultured neonatal rat
ventricular myocytes (NRVMs) were treated with a simulated I/R injury to verify cardiomyocyte
specificity. The essential autophagy gene, ATG7, conditional cardiomyocyte-specific knockout
(ATG7 cKO) mice, and isolated adult mouse ventricular myocytes (AMVMs) were used to
evaluate the dependency of autophagy in adult cardiomyocytes. In NRVMs subjected to I/R, TB
increased autophagic flux, mtDNA content, mitochondrial function, reduced reactive oxygen species
(ROS), and mtDNA damage. Similarly, in the infarct border zone of the mouse heart, TB induced
autophagy, increased mitochondrial size and mtDNA content, and promoted the expression of PGC1α
and mitochondrial dynamic genes. Conversely, loss of ATG7 in AMVMs and in the myocardium of ATG7
cKO mice abolished the beneficial effects of TB on mitochondrial homeostasis. Thus, autophagic flux is a
sufficient and essential process to mitigate myocardial reperfusion injury by maintaining mitochondrial
homeostasis and partly by inducing PGC1α-mediated mitochondrial biogenesis.
Keywords: autophagy; mitochondrial biogenesis; mitochondrial dynamics; ROS; myocardial
ischemia/reperfusion injury
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1. Introduction
After acute myocardial infarction (MI), early reperfusion is the key to reducing infarct
size [1]. However, the reperfusion part of the ischemia/reperfusion (I/R) injury is also a
significant part of deciding myocardial infarct size, accounting for around 50% of the final
infarct size [1]. Many pathophysiologic mechanisms lead to myocardial I/R injury, such
as ion accumulation, free radical formation/reactive oxygen species (ROS), endothelial
dysfunction, inflammation, and immune activation [2]. To mitigate reperfusion injury, many
clinical trials were conducted to evaluate the effectiveness of therapies such as ischemia
remote conditioning, adenosine, and cyclosporine infusion [3]. Some have shown beneficial
effects in small clinical trials, but all failed to improve clinical outcomes in subsequent large
clinical trials [3,4]. Thus, for now, there is no standard therapy to mitigate reperfusion
injury [5]. Clinically appropriate and effective treatment is needed to minimize reperfusion
injury, and a detailed understanding of the molecular biological pathways of reperfusion
injury is vital for developing therapies.
Previous animal studies have shown that histone deacetylases (HDAC) inhibitors
have strong cardioprotection in mouse models of I/R injury. Notably, we reported that
an FDA-approved anticancer HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA,
Vorinostat (Zolinza® , Merck, Rahway, NJ, USA)), reduces infarct size by 40% and blunts I/R
injury by maintaining autophagic flux when given at the time of reperfusion in rabbits [6].
Our following study demonstrated that the protective benefits of SAHA are not only dependent on autophagy but also on increasing mitochondrial biogenesis, which is mediated
by peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC1α) [7].
However, as an anticancer medication, HDAC inhibition has pleiotropic effects; some are
unwanted [8]. We have tested a specific autophagy-inducing peptide, Tat-Beclin 1 (TB) [9],
in a mouse cardiac I/R model. The only known cellular effect of TB is inducing autophagy,
which allows us to study the effect of autophagy on cardiac I/R injury. We found that TB
reduces infarct size when given at the time of reperfusion and reduces ROS formation [10].
Two major processes tightly regulate mitochondrial homeostasis: degradation of damaged mitochondria by autophagy (mitophagy) and mitochondrial biogenesis [11]. Our
prior study showed that SAHA induces both autophagic flux and mitochondrial biogenesis
mediated by PGC1α [7]. SAHA affects multiple pathways by enhancing acetylation of
histones (gene expression) and acetylation of signaling proteins (post-translational regulation) [12]. For example, recent studies have shown that HDAC inhibition affects the
mTOR signaling pathway [10,13] and affects the fatty acid metabolism by inhibiting succinate dehydrogenase [14]. Thus, it is possible that SAHA induces PGC1α through these
pathways, not only autophagy. Whether autophagic flux induced by TB without affecting
the mTOR or cardiac metabolism maintains mitochondrial homeostasis is unknown. This
study aimed to test the effects of TB-induced autophagic flux on cardiomyocyte mitochondrial biogenesis and homeostasis during I/R injury in vitro and in vivo. We showed that
TB-induced autophagic flux reduces ROS and increases mitochondrial mtDNA level and
function measured by oxygen consumption rate (OCR) using Seahorse, PGC1α expression,
and mitochondrial dynamic genes during I/R injury, which depends on ATG7 in adult
mouse cardiomyocytes.
2. Methods and Materials
2.1. Experimental Animals
All animal protocols were approved by the Animal Care and Use Committee of the
University of Alabama at Birmingham. All mice used in this study were male with free
access to feeding and water. They were all housed in a pathogen-free environment, with a
standard light/dark cycle of 12:12 h.

Cells 2022, 11, 2111

3 of 21

2.2. Generation of Inducible Cardiomyocyte-Specific ATG7 Knockout Mice
The inducible cardiomyocyte-specific ATG7 knockout mice were generated as previously described [7]. Briefly, the ATG7F/F mouse was obtained from Dr. Massaki Komatsu [15], and the αMHC-merCremer mouse was purchased from Jackson’s lab [16].
Tamoxifen was administered IP at 20 mg/kg 1 week before the experiment for 5 days to
8–12-week-old mice [17]. With the tamoxifen injection, the inducible myocardium-specific
ATG7 knockout mice, αMHC-merCremer+; ATG7F/F (ATG7 cKO (KO)), were generated.
ATG7F/F treated with tamoxifen injection (WT) were used as control. Within 1 week after
the last injection, inducible cardiomyocyte-specific ATG7 knockout (KO) and wild-type
(WT) littermate control mice were subjected to I/R surgeries or isolation of AMVMs.
2.3. Mouse I/R Model
Eight- to twelve-week-old male C57BL/6J wild-type mice or ATG7 cKO or WT littermate control mice were used for mouse I/R surgeries. Briefly, mice were anesthetized
with isoflurane and placed in a supine position on an electric heating pad (37 ◦ C). Animals
were intubated and ventilated. Following the left thoracotomy, the left anterior descending
coronary artery was visualized under a microscope and ligated with a reversible knot, and
regional ischemia was confirmed visually. Then the ligation was released after 45 min of
ischemia. Please refer to the detailed protocol in prior publications [6,7]. Specific effects of
the TB were controlled by the control peptide, Tat-Scrambled (TS) [9]. For the control group,
mice received TS 20 mg/kg intraperitoneal (IP) injection at the time of reperfusion [10].
For the TB experiment group, mice were given TB 20 mg/kg IP injection at reperfusion.
The heart was treated with 45 min ischemia and 24 h of reperfusion. Then, the mice were
euthanized, and, using a dissecting microscope, the heart was cut into three tissue zones:
infarct zone (I), border zone (B), and remote zone (R). Some pieces of the heart were used
for electron microscopy. Then, the samples were homogenized and divided for subsequent
Western blot, DNA, and RNA isolation for real-time qPCR and qRT-PCR analyses.
2.4. Primary Culture of Neonatal Rat Ventricular Myocytes
Ventricles from 1- to 2-day-old Sprague-Dawley rats with mixed-sex were collected and
digested using a neonatal mouse/rat cardiomyocyte isolation system (Neomyt Kit, NC6031,
Cellutron, Baltimore, MD, USA). The resulting cell suspension was preplated to clear
fibroblasts. These neonatal rat ventricular myocyte (NRVMs) cells were plated and cultured
for 24 h in DMEM/M199 (3:1 ratio) containing 5% fetal bovine serum and 100 µmol/L
bromodeoxyuridine (Sigma Aldrich, St. Louis, MO, USA) to prevent noncardiomyocyte
growth, and then in serum-free culture media 2–3 days for treatment and subsequent
harvest. Typical cultures were notable for >95% cardiomyocytes.
2.5. Adult Mouse Cardiomyocyte (AMVM) Isolation
The AMVM isolation was performed as previously described [18] with slight modifications using a Langendorff perfusion system. Briefly, the heart of each male mouse
was cannulated through the aorta and perfused with perfusion buffer (in mM: 113 NaCl,
4.7 KCl, 0.6 KH2 PO4 , 0.6 Na2 HPO4 , 1.2 MgSO4 , 12 NaHCO3 , 10 KHCO3 , 10 HEPES,
30 taurine, 10 BDM, and 5.5 glucose) after isolating from the adult mouse, followed
by digestion buffer (perfusion buffer supplemented with 300 U/mL collagenase II and
1.5 mg/mL proteinase XIV). Then, the heart was minced and filtered through a 100 µm-cell
strainer. The concentration of Ca2+ was gradually increased to a final concentration of
900 µM with repeated centrifugation and resuspension. Finally, the cells were resuspended
and plated on laminin-coated tissue culture dishes in the plating medium (DMEM 4.5 g/L
glucose, supplemented with FBS, blebbistatin, and penicillin/streptomycin) at 37 ◦ C and
5% CO2 for 1–3 hours. Then the cells were cultured with DMEM 4.5 g/L glucose supplemented with BSA and blebbistatin. Cell purity was greater than 98% of cardiomyocytes.
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2.6. Simulated I/R in Cultured Cells
Simulated I/R of cardiomyocytes was performed as described before [6,7]. Briefly,
ischemia was performed using an ischemia-mimetic solution and a humidified gas chamber
with 95% N2 and 5% CO2 . After 2 h of simulated ischemia, reperfusion was initiated by
changing to a normoxic NRVM culture medium with 5% horse serum and incubation in
an incubator with 95% room air, 5% CO2 [19]. Controls incubated in a normoxic NRVM
culture medium with 5% horse serum were prepared in parallel for each condition. An
amount of 2.5 µmol/L TB or TS was added at reperfusion in acidified Opti-MEM media [9]
for a total of 4 to 6 h of treatment in the group in which cells were treated with sI/R of 2 h
ischemia and 4 to 6 h of reperfusion. LC3 Western blots with bafilomycin A were performed
to assay autophagic flux. For the AMVM, the ischemia time was 1 h, and the reperfusion
time was 2–4 h.
2.7. Reagents
GAPDH (10R-G109a, Fitzgerald, Acton, MA, USA), ATG7 (#2631, Cell Signaling
Technology, Danvers, MA, USA), Fis1 (# PA5-22142, Invitrogen, Thermo Fisher Scientific,
Waltham, MA, USA), Drp1 (ab184247, Abcam, Waltham, MA, USA), Mfn1 (sc-166644, Santa
Cruz Biotechnology, Dallas, TX, USA), and Mfn2 (ab50843, Abcam, Waltham, MA, USA)
antibodies were purchased. Rabbit anti-LC3 polyclonal antibody was given to us as a
generous gift from Dr. Hill’s lab (UT Southwestern Medical Center, Dallas, TX, USA). TS
and TB were purchased from Sigma (customized Tat-Beclin 1, YGRKKRRQRRRGGTNVFNATFEIWHDGEFGT, Tat-Scrambled, YGRKKRRQRRRGGVGNDFFINHETTGFATEW).
Bafilomycin A was purchased from LC laboratories (B-1080, LC Laboratories, Woburn,
MA, USA).
2.8. Fluorescent Microscopy
Dichlorofluorescein (H2DCFDA, MP36103, 10 µM, Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA), MitoSOX Red (M36008, 5 µM, Invitrogen, Thermo Fisher
Scientific, Waltham, MA, USA), and tetramethylrhodamine methylester (TMRM, I34361,
T668, 0.1 µM, Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) were used to
measure cellular ROS levels, mitochondrial ROS levels, and mitochondrial membrane potential, respectively. As previously described [7], NRVMs were incubated in H2DCFDA for
30 min, in MitoSOX for 10 min, and in TMRM for 30 min. Images were immediately
captured by using a Nikon Eclipse Ti fluorescent microscope. We used the ImageJ software (1.53, NIH, Bethesda, MD, USA) to determine the average fluorescence intensity of
H2DCFDA, MitoSOX, and TMRM in each group.
2.9. Isolation of DNA and RNA, Measurement of mtDNA Copy Number, and mtDNA Damage
Following the previous protocols [7], total DNA and RNA were isolated from NRVMs,
AMVMs, and the three zones of the mouse hearts. Mitochondrial DNA (mtDNA) content, intact mtDNA (16.2 kb), and total mtDNA (0.22 kb) were measured by quantitative
PCR (qPCR) and semiquantitative PCR as described before [7,20]. Data were expressed
as the ratio of the intact mtDNA divided by the total mtDNA for each group. A decreased intact/total ratio is indicative of increased mtDNA damage. ImageQuant (V7,
GE Healthcare, Chicago, IL, USA) was used to quantify the density of semiquantitative
PCR products. Mitochondrial DNA-specific gene ATP6 or COXII primers were used to
perform the qRT-PCR.
2.10. Assays of Cell Death
NRVMs cell death was detected by using an MTT Assay Kit (V13154, 5 mg/mL,
Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA). NRVMs were treated with sI/R
of 5 h ischemia and 3 h of reperfusion, then changed to phenol red-free culture medium
(in mM: 130 NaCl, 4 KCl, 1.25 MgSO4 , 1.2 CaCl2 , 6.25 NaHCO3 , 20 HEPES, 20 D glucose)
with 10% MTT solution. Incubated at 37 ◦ C overnight, we then added SDS-HCl solution
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(SDS 0.1 g/mL, 0.01 M HCl), the same volume of the culture medium to mix. Incubated at
37 ◦ C for 4 h, then pipetted well to mix sample again, and read the absorbance at 570 nm.
AMVMs were treated with sI/R of 1 h of ischemia and 4 h of reperfusion. A Nikon Eclipse
Ti fluorescent microscope was used to take images at the same magnification in the bright
field before sI/R and after 4 h of reperfusion. Live cell numbers were counted by using
ImageJ software (1.53, NIH, Bethesda, MD, USA).
2.11. Electron Microscope (EM)
EM was performed as described before [7]. A Tecnai Spirit T12 transmission electron
microscope, operating at 20 to 120 kV and equipped with a digital camera, was used
to image the heart sections. Mitochondria numbers and size were analyzed by using
ImageJ software (1.53, NIH, Bethesda, MD, USA). The EM image reader was blinded for
group assignment, and the mitochondrial number and size were an average of 4–6 images
per mouse.
2.12. ATP Concentration Measurement in AMVMs
The ATP levels in AMVMs were detected by using an ATP Determination Kit (A22066,
Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA). AMVMs were treated with sI/R
of 1 h of ischemia and 2 h of reperfusion. Boiling water was used to inhibit ATPase [21].
AMVMs suspension was collected and centrifuged at 12,000× g for 5 min at 4 ◦ C. The
supernatant was used for bioluminescence measurement and read at 560 nm. The standard
curve of ATP was obtained by serial dilutions of 10 nM ATP solution.
2.13. Cellular Bioenergetics
Analyses of cellular bioenergetics were performed using the Seahorse XFe96 Extracellular Flux Analyzer (Agilent, Santa Clara, CA, USA) [22,23]. After isolation, the NRVMs
were plated into an Agilent Seahorse XF96 cell culture microplate (Product No.101085-004)
at 28,000 cells/well for 4 days. On the day of the experiment, the cells were exposed to 2 h
of ischemia as described above, then 2.5 µM TS/TB was added for a 4-hour reperfusion.
After IR or normoxia, the cells were changed into the XF media (nonbuffered DMEM
supplemented with 5.5 mM glucose, 1 mM pyruvate, and 4 mM glutamine, pH 7.36) at
37 ◦ C. Oxygen consumption rate (OCR) was measured for basal OCR (OCR before
oligomycin minus OCR after antimycin) followed by sequential injections of 1 µg/mL
oligomycin, 1 µM FCCP, and 10 µM antimycin A. Mitochondrial parameters were calculated for ATP-linked (OCR before oligomycin minus OCR after oligomycin), proton leak
(OCR after oligomycin minus OCR after antimycin), maximal (OCR after FCCP minus OCR
after antimycin), reserve capacity (OCR after FCCP minus OCR before oligomycin), and
nonmitochondrial (OCR after antimycin).
2.14. Statistical Methods
Averaged data are reported as mean ± standard error of the mean. Data were analyzed
with the unpaired Student t test for 2 independent groups, paired t test for dependent
data, and the 1-way or 2-way analysis of variance followed by the Tukey’s post hoc test
for pairwise comparisons. Studies with repeat measures were analyzed using repeatedmeasures analysis of variance. For all statistical tests, a p value of <0.05 was considered
statistically significant, and all tests were 2-tailed. All statistical analyses were performed
using GraphPad Prism (version 8.0.2, GraphPad Software, San Diego, CA, USA) software. Detailed statistical methods that were used for each set of data are listed in the
online supplemental.
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3. Results
3.1. Tat-Beclin 1 Induces Autophagy and Reduces Oxidative Stress in Neonatal Rat Ventricular
Cardiomyocytes (NRVMs) Simulated I/R Injury

Cells 2022, 11, x FOR PEER REVIEW

Autophagy is a conserved intracellular process to recycle cellular contents, including
damaged organelles [24]. Previous studies demonstrated that the activation of autophagy
during reperfusion could reduce infarct size [25,26]. TB has an 18 amino acid region of the
essential autophagy gene Beclin-1 that can induce autophagy by releasing native Beclin-1
from its inhibitor GAPR-1 to promote autophagy [9]. The only known function of TB is to
induce autophagy. Autophagy is a dynamic process of flux. So, an increased steady-state
level of autophagosome or autophagosome-related proteins means either an increase in
autophagic flux, or a block in downstream lysosomal processing of these autophagosomes,
or both [24]. To measure the autophagic flux, we used bafilomycin A as a lysosomal activity
blocker to block the downstream processing. Autophagy was evaluated by Western blot
detection of the autophagosome-associated lipidated isoform of LC3 (LC3-II). NRVMs were
exposed to sI/R (2 h of ischemia and 4 h of reperfusion) with the treatment of TS/TB at the
reperfusion time. In the TS group, steady-state levels of LC3-II were slightly decreased after
I/R injury. Reduced levels of LC3-II demonstrated a decline in autophagic flux in the TS
group observed after bafilomycin A treatment. With the absence of bafilomycin A, LC3-II
levels were similar in both TS and TB treatment groups. However, blocking lysosomal
activity by bafilomycin A revealed a significant increase in autophagic flux induced by TB,
as proved by the accumulation of LC3-II (Figure 1A,B).
Many studies have uncovered the role of ROS in cardiac I/R injury, which shows
ROS is an important contributor to I/R injury, especially mitochondrial ROS [27]. Limiting
the generation of ROS can reduce infarct size and cardiac I/R injury [28]. Therefore, we
examined the ROS levels in NRVMs subjected to I/R (sI/R, 2 h of ischemia and 4 h of
reperfusion) injury with TS or TB treatments at the time of reperfusion. We used H2DCFDA
and MitoSOX staining to quantify cellular and mitochondrial ROS levels in cardiomyocytes
by microscopy. Cytosolic ROS levels after I/R were significantly increased in the TS-treated
control group, while the ROS levels were reduced significantly in the TB-treated group
(Figure 1C,D). Similar results were observed in the mitochondrial ROS levels measured
by mitoSOX (Figure 1E,F). In aggregate, these data indicate that during I/R injury, TB
7 of 23
treatment in NRVMs increases autophagic flux and suppresses I/R-induced damaging
cytosolic ROS levels.

Figure 1. Cont.
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Figure 1. Tat-Beclin 1 induces autophagy and reduces oxidative stress in neonatal rat ventricular

Figure 1. Tat-Beclin 1 induces autophagy and reduces oxidative stress in neonatal rat ventricular
cardiomyocytes (NRVMs) treated with simulated I/R injury. NRVMs were treated with simulated
cardiomyocytes (NRVMs) treated with simulated I/R injury. NRVMs were treated with simulated
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ROS is an important contributor to I/R injury, especially mitochondrial ROS [27]. Limiting the generation of ROS can reduce infarct size and cardiac I/R injury [28]. Therefore,
3.2. Tat-Beclin 1 Treatment Increases Mitochondrial DNA Levels, Partially Maintains
we examined the ROS levels in NRVMs subjected to I/R (sI/R, 2 h of ischemia and 4 h of
Mitochondrial Function, and Reduces Cell Death in Cardiomyocytes Subjected to Simulated
reperfusion) injury with TS or TB treatments at the time of reperfusion. We used

I/R Injury

Mitochondria, the major source of ROS and the major antioxidant producers, play a
critical role in many cell mediating processes [29]. Moreover, mitochondria are the major
targets for ROS damage [27]. Damaged mitochondria will initiate cell death pathways, contributing to cardiomyocyte death and heart failure [30]. Excessive generation of ROS during
reperfusion injury damages mitochondrial DNA (mtDNA), protein, and lipids, which leads
to more ROS production and, as a vicious circle, causes mitochondrial dysfunction [31].
Thus, mitochondrial homeostasis is a critical target to mitigate I/R injury by maintaining
energy production and reducing ROS levels. We have shown that TB reduced ROS levels in
NRVMs. We next analyzed whether TB would affect mtDNA levels during I/R injury. We
measured the intact and total mtDNA (16.2 and 0.22 kb, respectively) using semi-qPCR to
evaluate mtDNA levels in NRVMs [20]. The ratio of intact mtDNA to total mtDNA serves
as an indicator of mtDNA damage. We used 6 h of reperfusion to show the later effects
on mitochondrial DNA. During I/R, the intact/total mtDNA ratio in TS treatment group
cardiomyocytes decreased, indicating mtDNA damage. Compared with the TS-treated
NRVMs subject to I/R injury, the intact/total mtDNA ratio in the TB treatment group was
significantly higher (Figure 2A,B). For the total mtDNA levels, the mtDNA copy numbers of
ATP6 and COX-II during I/R in NRVMs were significantly increased by with the treatment
of TB compared with the TS group. In the normoxia group, there was a trend of increasing
mtDNA with the TB treatment (Figure 2C,D).

Figure 2. Cont.

Cells 2022, 11, 2111

8 of 21

Figure 2. Tat-Beclin 1 increases mitochondrial DNA levels, and partially maintains mitochondrial
membrane potential and cellular bioenergetics in NRVMs treated with simulated I/R injury. NRVMs
were treated with TS or TB at the time of reperfusion. After simulated I/R injury of 2 h of ischemia
and 4 to 6 h of reperfusion, DNA was extracted and amplified to evaluate mtDNA damage and
integrity. (A,B), representative DNA gel of the intact mtDNA (16.2 kb) and total mtDNA (0.22 kb)
products from semi-qPCR and quantification of the 16.2 kb/0.22 kb ratio in NRVMs. n = 3. Normoxia
TS vs. IR TS, p = 0.024. IR TS vs. IR TB, p = 0.0022. (C,D), rat-specific ATP6 and COX-II primers
for real-time qPCR were used to analyze mtDNA copy numbers in NRVMs. n = 3, ATP6, normoxia
TS vs. IR TS, p = NS (not significant). IR TS vs. IR TB, p = 0.0117. COX-II, normoxia TS vs. IR TS,
p = NS. IR TS vs. IR TB, p = 0.0009. To evaluate mitochondrial membrane potential, TMRM staining
was used in NRVMs after IR. (E,F), representative images of TMRM staining and quantification of
NRVMs under normoxia or I/R conditions. Bar = 100 µm. n = 4. Normoxia TS vs. IR TS, p = 0.0001.
IR TS vs. IR TB, p = 0.001. (G–L), oxygen consumption rates for NRVMs were measured by using
a Seahorse XFe96 Analyzer. (G). Representative OCR measurement is shown. Each parameter was
calculated based on 5 independent experiments. All parameters were normalized to normoxia TS
values. (H). Basal OCR, NS across groups. (I). ATP linked OCR, NS across groups. (J). Proton leak
OCR, NS across groups. (K). Maximal OCR, normoxia TS vs. IR TS, p = 0.0448, IR TS vs. IR TB,
p = 0.0009. (L). reserve capacity OCR, normoxia TS vs. IR TS, p = 0.0217, IR TS vs. IR TB, p = 0.0097.
TS, Tat-Scrambled; TB, Tat-Beclin 1. I2R4, ischemia 2 h and reperfusion 4 h; I2R6, ischemia 2 h and
reperfusion 6 h; NS (not significant).

Mitochondrial membrane potential plays a crucial role in mitochondrial function.
During I/R, cellular calcium increases, and subsequent activation of caspases leads to
the failure of mitochondrial membrane potential and results in cell death [30]. We next
measured the mitochondrial membrane potential of NRVMs by using TMRM staining
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and visualized by fluorescence microscopy. We found a significant decrease in TMRM
fluorescence after I/R in the TS group. By contrast, TB treatment preserved mitochondrial
membrane potential after I/R (Figure 2E,F).
Mitochondrial oxidative phosphorylation is required to generate ATP and restore
calcium gradients following cardiac ischemia–reperfusion [32]. We found that TB maintains mitochondrial membrane potential after I/R, similar to SAHA [7]. Recent advances
in measuring bioenergetics using Seahorse have opened the door to measuring cardiac
mitochondrial function [33]. We optimized the protocol to measure oxygen consumption
rate (OCR) in cardiomyocytes. Then, we measured the cellular bioenergetics by measuring
the OCR in NRVMs and the cellular ATP concentration of AMVMs subjected to I/R injury.
There was no significant difference between the OCR of the TS- and TB-treated group in the
normoxia treatment. However, after I/R, the maximal and the reserve capacity OCR was
lower in the TS-treated group, and TB partially preserved these parameters (Figure 2K,L).
There was no difference between the TS and TB groups after I/R in other OCR measurements, including basal, ATP linked, and proton leak (Figure 2H–J). This indicates that TB
treatment partially protects cellular bioenergetic function post-I/R injury. Of note, this is
different from the effect of HDAC inhibition on OCR in cardiomyocytes during I/R injury,
which reduces the OCR and also affects fatty acid metabolism [14]. Due to the limited
number of AMVMs, we measured the ATP concentration in AMVMs subjected to I/R.
TB increased ATP levels in both the normoxia and I/R treatment groups (Figure S1C),
suggesting that TB has similar protective effects in AMVMs. As mitochondria also play
an important part in several types of cell death [29], we measured cardiomyocyte viability
after I/R. Before and after I1R4, viable AMVMs were counted. TB reduced AMVMs death
significantly after I/R (Figure S1A,B). Similar to our published data [10], the MTT assay
in NRVMs showed that the TB group had higher viability than the TS group after I/R
injury (Figure S1C). In summary, TB partially preserves intact functional mtDNA, maintains
cardiomyocytes’ bioenergetics, and reduces cell death after I/R.
3.3. Tat-Beclin 1 Treatment Induces Autophagy and Maintains Mitochondrial Homeostasis in
Mouse Myocardium Treated with I/R Injury
We established the beneficial effects of TB on autophagy and mtDNA during I/R
in vitro. To further explore the effects of TB in vivo, wild-type C57BL/6J mice were subjected to cardiac I/R injury, and TS/TB was given at the time of reperfusion. After 45 min of
ischemia and 24 h of reperfusion, mice were euthanized, and the hearts were isolated and
divided into three tissue zones: infarct zone (I), border zone (B), and remote zone (R) as in
the previous studies [6,7]. The remote zone was considered myocardium without ischemia.
In the border zone, LC3-II levels in the TB-treated group increased significantly more
than in the TS-treated group. In the ischemic and remote zones, the LC3-II levels in the
TB-treated groups were also higher but did not reach statistical significance (Figure 3A,B).
Similarly, mtDNA content detected by real-time qPCR using primers specific to ATP6 and
COX-II in the border zone was also significantly increased in the TB group compared with
the TS group (Figure 3C,D). In summary, TB induced an increase in LC3-II after I/R in
the mouse heart border zone, suggesting increased autophagic flux, and the increased
autophagic flux preserved mtDNA content.

Figure 3. Cont.

Cells 2022, 11, 2111

10 of 21

Figure 3. Tat-Beclin 1 treatment induces autophagy, maintains mitochondrial DNA levels, and
increases PGC1a and mitochondrial dynamic gene expression and mitochondrial area in mouse
heart with I/R injury. Mice were subjected to cardiac I/R injury (45 min/24 h) and treated with
Tat-Scrambled or Tat-Beclin 1 during reperfusion, and then the left ventricle was cut into three distinct
zones (infarct, border, and remote). Whole tissue lysate was extracted for Western blot, DNA and
RNA were isolated for quantification of mtDNA, and mitochondrial biogenesis and fission and fusion
related genes. EM images were also obtained. (A,B), representative Western blot, and quantification
of LC3-II expression in three zones of mouse heart subjected to I/R. n = 5, p = 0.0054. (C,D), ATP6
and COX-II primers were used to determine the mtDNA copy number in three zones of I/R treated
mouse heart. n = 6. ATP6, p = 0.0363. COX-II, p = 0.0394 (border zone). (E), PGC1α gene expression in
the mouse heart subjected to I/R. n = 5, p = 0.0311 (border zone). (F,G), mitochondrial fission-related
gene expression in mouse heart subjected to I/R. n = 6–7. TS vs. TB, Drp1, p = 0.0292. Fis1, p = 0.3763
(border zone). (H–J), mitochondrial fusion-related gene expression in mouse heart subjected to I/R.
n = 6–7. TS vs. TB, Opa1, p = 0.0091. Mfn1, p = 0.0444. Mfn2, p = 0.0323 (border zone). (K,L),
EM images of mitochondria in the mouse heart infarct border zone. Bar = 1µm. n = 4. TS vs. TB,
mitochondria numbers, p = NS. Mitochondria size, p = 0.0282. TS, Tat-Scrambled; TB, Tat-Beclin;
I, infarct zone; B, border zone; R, remote zone; NS (not significant).
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Next, we evaluated the effect of TB on mitochondrial biogenesis and fission- and fusionrelated gene expression in the mouse heart subjected to I/R injury. PGC1α gene expression
in the border zone of the TB group was significantly increased compared to the TS group,
indicating possible increased PGC1α-mediated mitochondrial biogenesis (Figure 3E). Since
mitochondrial homeostasis is a dynamic process involving mitochondrial fission and
fusion [34], we then measured the expression of mitochondrial dynamic genes. In the
infarct border zone of the mouse heart with I/R injury, the expression of mitochondrial
fission gene, Drp1 (Figure 3F), and fusion genes Opa1, Mfn1, and Mfn2 (Figure 3H–J)
were significantly induced in the TB group than the TS group. The fission gene, Fis1,
had a trend of increase but did not reach statistical significance in the TB group. These
indicated that TB increased mitochondrial dynamics in the mouse heart border zone
subjected to I/R injury. We had reported that SAHA treatment increases autophagosomes
in rabbits and increases mitochondrial size in the mouse heart border zone using EM [6,7].
Similarly, we observed an increase in autophagosomes in the TB-treated group than in
the TS group in the border zone, with autophagosomes engulfing damaged mitochondria
in EM images (Figure S2B). TB also increased the mitochondrial size in the mouse heart
infarct border zone (Figure 3K,L). The mitochondrial sizes in the ischemic and remote zones
were not significantly different (Figure S2A). Collectively, these results indicate that TB
treatment maintained mitochondrial homeostasis in the border zone in mouse hearts during
I/R injury.
3.4. Tat-Beclin 1 Increases Mitochondrial Biogenesis and Dynamics, Which Is Dependent on the
Essential Autophagy Gene, ATG7, in Adult Mouse Ventricular Cardiomyocytes (AMVMs)
Mitochondrial biogenesis is partially regulated by PGC1α, a central orchestrator
of oxidative metabolism [35,36]. Importantly, in the kidney and brain, mitochondrial
biogenesis is not increased by I/R injury, despite induction of PGC1α, suggesting removal
of damaged mitochondria is needed to allow mitochondrial biogenesis. We have shown
that SAHA protects hearts from I/R injury by inducing both autophagy and PGC1αdependent mitochondrial biogenesis, and SAHA’s protective effects on mtDNA depend
on PGC1α, which indicates the subsequent PGC1α-mediated mitochondrial biogenesis
is needed for mitochondrial homeostasis even with increased autophagy [7]. By using
NRVMs, we have also shown that SAHA’s cardiac protective effects in PGC1α-mediated
mitochondrial biogenesis are cardiomyocytes specific [7]. Since the NRVMs are not mature
cardiomyocytes, this time, we tested the effects of TB on PGC1α expression in AMVMs
lacking ATG7.
Inducible cardiomyocyte-specific ATG7 knockout mice (αMHC-merCremer+;
ATG7F/F treated with tamoxifen, ATG7 cKO (KO)) were generated as described before [7],
and the loss of ATG7 was verified both by Western blots and qRT-PCR in isolated AMVMs
(Figure 4A–C). The loss of ATG7 essentially abolished autophagic flux as shown in the
LC3 Western blot (Figure 4A). ATG7F/F treated with tamoxifen injection were used as
wild-type (WT) control. At baseline condition, TB increased PGC1α gene expression in
WT cardiomyocytes up to 70% (Figure 4D). To see the effects of autophagic flux induced
by TB on mitochondrial dynamics, we assessed the expressions of five genes, Drp1 and
Fis1, which are associated with mitochondrial fission, and Opa1, Mfn1, and Mfn2, which
are associated with fusion. Similar to the expression of PGC1α, TB treatment significantly
increased the expression of Drp1, Fis1, Mfn1, and Mfn2 (Figure 5H,I). The fusion gene,
Opa1, had a trend of increase but did not reach statistical significance in the WT group.
Together, these data showed that TB treatment induces PGC1α expression and promotes
mitochondrial dynamic gene expressions in AMVMs.
We have established that TB increases mtDNA content and increases PGC1α and
mitochondrial fission and fusion genes in AMVMs. However, since TB is a peptide that
may regulate other pathways rather than only inducing autophagy, we next tested whether
TB’s effects on mitochondria are dependent on the crucial autophagy-related gene, ATG7.
TB increased PGC1α gene expression in the WT mice group compared with TS. In ATG7
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cardiomyocyte null mice, TB was not sufficient to induce the PGC1α expression (Figure 4D).
Regarding the mitochondrial fission and fusion genes, TB-induced mitochondrial fission
and fusion gene expressions were abolished in ATG7 cKO AMVMs (Figure 4E–I). In
addition, TB increased mtDNA copy number of ATP6 was blocked by the loss of the
ATG7 gene (Figure 4J). Together, these results demonstrate that TB’s ability to maintain
mitochondrial homeostasis is dependent on autophagy in the AMVMs.
The detailed pathway of how TB increases PGC1α gene expression is unknown. We
tested two upstream regulators of PGC1α gene, NRF2 [37] and PARIS [38], but no significant
change was found (Figure S3B). However, this does not exclude that these factors may
still regulate PGC1α expression since these proteins are post-translationally modified, and
further investigation is required. We also tested the expression levels of proteins related
to mitochondrial fission and fusion. The Mfn2 level was increased, Fis1, Drp1,
and Mfn1
14 of 23
had some trend but did not reach significance (Figure S4A,B), also suggesting the role of
post-translational modifications of these proteins.
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Figure 4. The beneficial effects of Tat-Beclin 1 on mitochondrial homeostasis in adult mouse ventricular cardiomyocytes (AMVMs) depend on autophagy. Mouse model of inducible cardiomyocytespecific ATG7 knockout mice (ATG7 cKO (KO)) were generated. ATG7F/F treated with tamoxifen
injection (WT) were used as control. AMVMs were treated with TS or TB for 2 h, DNA and RNA were
extracted for qPCR and qRT-PCR, respectively. (A,B), representative Western blot, and quantification
of ATG7 expression and LC3-II level in AMVMs. n = 3. WT vs. KO, ATG7, p = 0.0151. LC3-II,
p = 0.002. (C), ATG7 gene expression in AMVMs. n = 5–6. WT vs. KO, p = 0.0073. (D), PGC1α gene
expression in AMVMs. n = 5–6. TS vs. TB, WT, p = 0.0212. KO, p = NS. (E,F), mitochondrial dynamics
fission-related gene expression in AMVMs. n = 5–6. TS vs. TB, Drp1, WT, p = 0.048. KO, p = NS.
Fis1, WT, p = 0.0365. KO, p = NS. (G–I), mitochondrial dynamics fusion-related gene expression in
AMVMs. n = 5–6. TS vs. TB, Opa1, WT, p = 0.3713. KO, p = NS. Mfn1, WT, p = 0.0104. KO, p = NS.
were
Cells 2022, 11, x FOR PEER REVIEW Mfn2, WT, p = 0.0243. KO, p = NS. (J), mtDNA copy number in cardiomyocytes (AMVMs)
16 of
23
analyzed by qPCR of ATP6. n = 5–6. TS vs. TB, WT, p = 0.0494. KO, p = NS. TS, Tat-Scrambled; TB,
Tat-Beclin 1; NS (not significant).
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(A),
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Tat-Beclin 1 for 24 h, and the left ventricle was isolated for analysis. (A), ATG7 gene expression in
mouse heart. n = 9–10. WT vs. KO, p = 0.0002. (B), PGC1α gene expression in mouse heart. n = 4–6.
TS vs. TB, WT, p = 0.023. KO, p = NS (not significant). (C,D), mitochondrial dynamics fission-related
gene expression in mouse heart. n = 4–6. TS vs. TB, Drp1, WT, p = 0.0421. KO, p = NS. Fis1, WT,
p = 0.0216. KO, p = NS. (E–G), mitochondrial dynamics fusion-related gene expression in mouse
heart. n = 4–6. TS vs. TB, Opa1, WT, p = 0.0205. KO, p = NS. Mfn1, WT, p = 0.0121. KO, p = NS.
Mfn2, WT, p = 0.0459. KO, p = NS. (H), mtDNA copy numbers in mouse hearts were analyzed by
ATP6 qPCR. n = 4–6. TS vs. TB, WT, p = 0.0095. KO, p = NS. TS, Tat-Scrambled; TB, Tat-Beclin 1;
NS (not significant).

3.5. The Beneficial Effects of Tat-Beclin 1 on Mitochondria in Mouse Hearts Depend on Autophagy
After we established that TB induced beneficial mitochondrial effects in AMVM, we
moved on to test whether the same was true in the mouse myocardium. ATG7 cKO mice
were generated, and the loss of ATG7 gene expression was verified in the myocardium
(Figure 5A). The partial loss of ATG7 in the myocardium is due to the presence of other
types of cells in addition to cardiomyocytes. The mitochondrial biogenesis-related gene,
PGC1α, was increased in the WT mice TB group but not in the ATG7 cKO group (Figure 5B).
At the same time, TB-induced Drp1 and Fis1 (mitochondrial fission genes) expression were
lost in the absence of the ATG7 gene (Figure 5C,D). Similarly, TB-augmented mitochondrial
fusion gene expressions were abolished in the absence of the ATG7 gene in cardiomyocytes
(Figure 5E–G). Furthermore, the TB-induced mtDNA level increase measured by ATP6 gene
was abolished in ATG7 cKO mice (Figure 5H). Together, these data demonstrate that in the
mouse myocardium, TB maintains mitochondrial homeostasis via activating autophagy.
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4. Discussion
In cardiac I/R injury, approximately 50% of cell death is due to reperfusion injury,
for which there are no standard clinical therapies [5]. Many signaling pathways have
been manipulated to mitigate reperfusion injury without success [39]. Initial appropriate
mitochondrial quality control is critical for cardioprotection following I/R [3,40]. Previous studies reported that the HDAC inhibitor, SAHA, given at the time of reperfusion,
blunts I/R injury by inducing cardiomyocyte autophagy and maintaining mitochondrial
homeostasis [6,7]. Yet, as a nonselective HDAC inhibitor, SAHA has various untoward
effects. A better therapeutic is needed to induce autophagy specifically. We previously
showed that TB reduces infarct size when administered at the time of reperfusion [10].
Although SAHA induces mitochondrial biogenesis during cardiac I/R, it has other effects other than inducing autophagy, such as inhibiting the mTOR pathway and fatty
acid metabolism [10,13,14]. Whether pure autophagy activation maintains mitochondrial
homeostasis during I/R remains obscure. Tat-Beclin 1 was used to induce autophagic flux
by binding the Beclin 1 inhibitor GARP1 specifically without affecting mTOR and fatty
acid metabolism [9,10]. Here, we extended our research to test the effects of TB-induced
autophagic flux on ROS, and mitochondrial function and homeostasis. With this approach,
we discovered that direct activation of autophagic flux by TB can reduce I/R-induced ROS
levels. Furthermore, we found that TB treatment during reperfusion preserved mtDNA and
induced PGC1α mitochondrial biogenesis. Of note, the mitochondrial function measured
by OCR using Seahorse was significantly preserved by TB treatment at reperfusion, which
provided definitive evidence of improved mitochondrial function. We also identified the
beneficial effect of TB on the induction of cardiac mitochondrial fission and fusion genes
during I/R injury. Finally, we demonstrated that the benefit of mitochondrial homeostasis
of TB is cardiomyocyte-specific and through bona fide activation of autophagic flux by
silencing the essential autophagy gene, ATG7, in adult mouse cardiomyocytes.
4.1. Mitochondrial Homeostasis Is a Possible Therapeutic Target for I/R Injury
Mitochondria play an important role in regulating energy production and ROS regulation, which may be interrupted by pathological insults. Mitochondria are not only
essential for meeting cellular bioenergetic needs but also contribute to several types of cell
death and autophagy [29]. The natural compensation of mitochondria to these pathological
stimuli includes induction of antioxidant enzymes, mitochondrial biogenesis, increased
expression of respiratory complex subunits, and the metabolic shift to glycolysis [41,42].
Mitochondria may be generated in response to physiological or pathophysiological stimuli,
such as oxidative stress, increased energy requirements of the cells during exercise training,
electrical stimulation, changes of hormones during development, congenital mitochondrial
diseases, and cardiac I/R injury [42–44]. Thus, mitochondrial homeostasis, including removing damaged mitochondria and generating new mitochondria, is a potential target
for treating diseases lacking effective therapy, such as I/R injury in the heart and other
congenital mitochondrial diseases [45–47].
4.2. Autophagic Removal of Damaged Mitochondria Becomes an Effective Mechanism to Prevent
Cardiac Reperfusion Injury
Autophagy is an evolutionarily conserved process required for cellular constituent
recycling (including mitochondria), which is impaired during I/R [6,48]. One study has
shown that ROS overload induces mtDNA damage during cardiac reperfusion injury,
and if the damaged mitochondria cannot be cleared promptly, the cell will go into apoptosis [49]. Thus, the removal of damaged mitochondria by autophagy (mitophagy) is
essential for cardiomyocyte survival. We have reported previously that TB-induced autophagic flux reduced infarct size when given at the time of reperfusion [10]. We also
reported that the HDAC inhibitor, SAHA, reduces infarct size by 40% when given at the
time of reperfusion in rabbits through induction of autophagic flux and the promotion of
mitochondrial biogenesis in mouse myocardium [6,7]. However, HDAC inhibition has

Cells 2022, 11, 2111

16 of 21

broad effects and may have other unidentified off-target effects. To further explore the
role of autophagy on cardiac mitochondrial homeostasis in preventing reperfusion injury,
we reported here that TB peptide given at the time of myocardial reperfusion reduces
ROS levels and increases mtDNA levels, likely through PGC1α-mediated mitochondrial
biogenesis. Mitochondria are critical in the early responses to I/R injury. It has been reported that damaged mtDNA, opened permeability transition pore (PTP), ROS production,
and decreased ATP production by mitochondria in the myocardium occur during reperfusion injury [41,50]. In cardiomyocytes, autophagy promoted mitochondrial clearance
and improved mitochondrial function against oxidative stress-mediated damage [51]. We
believe that the initial appropriate mitochondrial quality control and reduction in ROS
production are critical for cardioprotection during reperfusion injury and provide ATP
for later responses and repair [52,53]. Autophagy might be more potent than mitophagy
alone in reducing reperfusion injury since it also removes other damaged organelles and
protein aggregates and generates energy for repair [3]. Our data showed that inducing
autophagic flux by Tat-Beclin 1 increases mitochondrial biogenesis and mitochondrial
dynamics gene expressions. We speculate that augmentation of mitophagy alone may also
have the same cardiomyocyte protection effects. However, the lack of a single powerful
mitophagy-inducing agent prevented us from testing this [54–56].
4.3. Tat-Beclin 1-Induced Autophagic Flux Maintains Mitochondrial Homeostasis and Possibly
Dynamics during Cardiac I/R Injury
Mitochondria are the primary source of ROS and also the major target for ROS damage [27]. Ischemia damages mitochondria complexes, and during reperfusion, excessive
ROS will be generated through reversed electron transport at complex I [57]. In turn, ROS
will further damage the mitochondria, resulting in a vicious cycle. To mitigate the I/R
injury, the vicious cycle needs to be stopped [31]. One way to do it is to remove the damaged mitochondria and replace them with new, functional mitochondria. Our data showed
that I/R-induced ROS production was blocked by the autophagic clearance of damaged
mitochondria. After removing damaged mitochondria, mitochondrial biogenesis is needed
to replete the depleted mitochondrial pool [58]. Our data showed that the mtDNA level
is increased after TB treatment in both the cardiomyocytes and the mouse myocardium.
These beneficial effects of TB on mitochondria are in the infarct border zone, where active
cell death happens during reperfusion injury. As noted, mitochondrial homeostasis is a
dynamic process; we demonstrated that TB increases mitochondrial biogenesis, possibly
through increasing PGC1α-mediated biogenesis and enhancing mitochondrial fission and
fusion during I/R injury. However, we only measured the fission and fusion gene and
protein expression, suggesting an increase in mitochondrial dynamic. Further studies on
mitochondrial fission and fusion need to be performed to verify this.
Since TB may have unintended effects in addition to inducing autophagic flux as it is
designed, we used ATG7 cKO mice to test whether loss of ATG7, an essential autophagyrelated protein, blocks TB’s beneficial effects. With the absence of the ATG7 gene, the
beneficial effects of the TB peptide are blocked, which confirms that TB’s beneficial effect
on mitochondria is through the genuine autophagy pathway. These data are consistent
with our previous study showing that HDAC inhibition’s beneficial effect on mitochondria depends on ATG7 in cardiomyocytes [7]. Additionally, because overactivation of
autophagy promotes pathologic cardiac remodeling [59], the therapeutic dose window
of TB is narrow [10]. We should take this into consideration when using TB in a possible
clinical trial.
4.4. The Mechanism of Autophagy Induced PGC1α-Mediated Mitochondrial Biogenesis
Besides autophagy, mitochondrial biogenesis is important in maintaining mitochondrial homeostasis during pathological stresses in I/R injury [11]. Mitochondrial biogenesis
is partially regulated by PGC1α, which is essential for metabolic function and oxidative
states [35,36]. Increased mitochondrial biogenesis through PGC1α after exercise contributes
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to improved recovery from I/R injury in the brain [60]. PGC1α can also be induced by I/R
injury with ROS overproduction in the brain and kidneys [61,62]. However, PGC1α induction alone did not reduce ROS production and I/R injury in the kidneys and brain since mitochondrial biogenesis might be overwhelmed and inhibited by the harmful consequences
of excessive mitochondrial damage [61,62]. Thus, PGC1α-dependent mitochondrial biogenesis may be autophagy-dependent during I/R. Consistent with this, autophagy is essential
for generating signals that promote exercise-induced mitochondrial biogenesis [63]. In
our study, PGC1α expression was significantly induced by TB-induced autophagic flux
in cardiomyocytes. This has not been reported before and has important implications for
using TB in maintaining mitochondrial homeostasis during I/R injury and even in other
congenital mitochondrial diseases [45–47]. The loss of ATG7 prevented TB from increasing PGC1α expression, which verified that TB-induced PGC1α expression is through the
autophagy pathway similar to HDAC inhibition [7]. We have tested two regulators of
PGC1α expression, Nrf2 and PARIS, but did not see any significant difference [37,38]. The
molecular mechanisms underlying autophagy-induced PGC1α-mediated mitochondrial
biogenesis need more investigation. We speculated that there might be sensors of the
mitochondria abundance level. The reduction in mitochondrial abundance by autophagic
removal during I/R may trigger the expression of mitochondrial biogenesis genes, such as
PGC1α. In addition, we showed that there are increases in both fission and fusion gene
expression after TB treatment. This is indicative of possible increased mitochondrial dynamics. However, more definitive studies need to be performed to evaluate mitochondrial
fission and fusion further.
5. Conclusions
20 of 23
Directly activated autophagic flux by a novel and powerful
autophagy-inducing
peptide, Tat-Beclin 1, reduces I/R-induced ROS levels and maintains mitochondrial homeostasis
during cardiac I/R injury. Induction of autophagic flux also augments PGC1α
Directly activated autophagic flux by a novel and powerful autophagy-inducing
expression,
therefore
regulating
biogenesis
in adult
peptide, Tat-Beclin
1, reduces
I/R-induced mitochondrial
ROS levels and maintains
mitochondrial
ho- cardiomyocytes. Furthermeostasis
during cardiac
I/R injury. Induction
autophagic flux
alsoof
augments
PGC1α
more,
induction
of autophagic
fluxofincreased
most
the mitochondrial
fission and fusion
expression, therefore regulating mitochondrial biogenesis in adult cardiomyocytes. Furgene
expression,
possible
mitochondrial
Additionally, these
thermore,
induction ofindicating
autophagic flux
increasedincreased
most of the mitochondrial
fissiondynamics.
and
fusion gene expression,
indicating
possible on
increased
mitochondrial
dynamics. Addiprotective
effects are
dependent
the essential
autophagy-related
gene, ATG7, in adult
tionally, these protective effects are dependent on the essential autophagy-related gene,
cardiomyocytes
(Figure
6).
Maintaining
appropriate
activation
of
autophagic flux and
ATG7, in adult cardiomyocytes (Figure 6). Maintaining appropriate activation of aumitochondrial
biogenesis
by
Tat-Beclin
1
or
other
agents
may
be
used
in future myocardial
tophagic flux and mitochondrial biogenesis by Tat-Beclin 1 or other agents may be used
in future myocardial
protection
clinical
trials in ST-elevation
myocardial
infarction patients.
paprotection
clinical
trials in
ST-elevation
myocardial
infarction

Cells 2022, 11, x FOR PEER REVIEW

tients.

Figure 6. Summary of the findings. Cardiac I/R induces mitochondrial damage and ROS produc-

Figure
6. Summary
of the findings.
Cardiac
I/R induces
mitochondrial
tion. Directly
activated autophagic
flux by a novel
and powerful
autophagy-inducing
peptide,damage and ROS production.
Tat-Beclin
1,
reduces
I/R-induced
ROS
level
and
increases
mitochondrial
homeostasis
during
carDirectly activated autophagic flux by a novel and powerful autophagy-inducing
peptide, Tat-Beclin 1,
diac I/R injury. Tat-Beclin 1’s cardioprotective effects are dependent on the crucial autophaCommented
“1”
reduces
ROS
andflux
increases
homeostasis
during
cardiac[M8]:
I/RAdd
injury.
gy-related I/R-induced
gene, ATG7. Induction
of level
autophagic
also seems mitochondrial
to induce mitochondrial
biogenesis
mediated by PGC1α and possibly increase mitochondrial dynamics (fission and fusion). The
Tat-Beclin 1’s cardioprotective effects are dependent on the crucial autophagy-related gene, ATG7.
mechanisms of autophagic flux-induced mitochondrial biogenesis and mitochondrial dynamics
Induction
of autophagic flux also seems to induce mitochondrial biogenesis mediated by PGC1α
need further investigation.
and
possibly
increase mitochondrial dynamics (fission and fusion). The mechanisms of autophagic
Supplementary Materials: The following supporting information can be downloaded at:
www.mdpi.com/xxx/s1,
Figure S1: TB biogenesis
reduces cell death
in both
adult mouse cardiomyocytes
flux-induced mitochondrial
and
mitochondrial
dynamics and
need further investigation.
neonatal rat ventricular cardiomyocytes; Figure S2: TB treatment does not affect mitochondrial
morphology in mouse ischemic and remote zones, but increases autophagosome in the border
zone; Figure S3: TB treatment increases PGC1α gene expression in AMVMs, but does not increase
the expression of two upstream regulators, NRF2 and PARIS; Figure S4: Mitochondrial fission and
fusion protein expression in AMVMs; Table S1: Sequences of forward and reverse primers used for
PCR; Table S2: Detailed statistical analysis information for all main and supplementary figures.
Author Contributions: L.H., Y.C. (Yuxin Chu), and J.Y. designed and conducted all experiments
with the exception of those listed below. J.H., Y.C. (Yunxi Chen), and Y.H. isolated cardiomyocytes

Cells 2022, 11, 2111

18 of 21

Supplementary Materials: The following supporting information can be downloaded at:
https://www.mdpi.com/article/10.3390/cells11132111/s1, Figure S1: TB reduces cell death in
both adult mouse cardiomyocytes and neonatal rat ventricular cardiomyocytes; Figure S2: TB treatment does not affect mitochondrial morphology in mouse ischemic and remote zones, but increases
autophagosome in the border zone; Figure S3: TB treatment increases PGC1α gene expression in
AMVMs, but does not increase the expression of two upstream regulators, NRF2 and PARIS; Figure S4:
Mitochondrial fission and fusion protein expression in AMVMs; Table S1: Sequences of forward and
reverse primers used for PCR; Table S2: Detailed statistical analysis information for all main and
supplementary figures.
Author Contributions: L.H., Y.C. (Yuxin Chu) and J.Y. designed and conducted all experiments with
the exception of those listed below. J.H., Y.C. (Yunxi Chen) and Y.H. isolated cardiomyocytes and
DNA and RNA, did qPCRs, and assisted other experiments. M.X. and Y.C. (Yunxi Chen) did the
cardiac I/R surgery. G.B., V.D.-U., G.C.R., L.Z., S.B., M.E.Y., S.D.P. and P.S. provided instrumentation,
reagents, and consultation on mitochondrial assays. S.B., M.E.Y., S.D.P., Y.Z. and C.Z. helped the
conception of this project and corrected the paper. M.X., L.H., Y.C. (Yuxin Chu) and J.Y. conceived
this project, analyzed the data, and wrote the manuscript. All authors have read and agreed to the
published version of the manuscript.
Funding: This work was supported by grants from NIH: K08-HL127305 (M.X.), R03-HL141620 (M.X.),
R01-HL153501 (M.X.), Early Career Development Award from Central Society for Clinical and Translational Research (CSCTR) (M.X.), UAB Nathan Shock Center P30 AG050886 (V.D.-U., S.B.), AHA
Postdoctoral fellowship 19POST34380984 (J.Y.).
Institutional Review Board Statement: All animal protocols were approved by the Animal Care and
Use Committee of the University of Alabama at Birmingham, IACUC-20202.
Data Availability Statement: Data is contained within the article or supplementary material. Detailed methods can be found in online Expanded Materials and Methods.
Acknowledgments: We acknowledge the secretary support from Amber Vickers. The LC3 antibody
was a gift from Joseph A. Hill at UT Southwestern Medical Center.
Conflicts of Interest: All authors have reported no conflict of interest.

Abbreviations
HDACs: histone deacetylases. TB: Tat-Beclin 1. TS: Tat-Scrambled. SAHA: suberoylanilide hydroxamic acid. DMSO: dimethyl sulfoxide.

References
1.
2.
3.
4.

5.
6.

7.

8.

Yellon, D.M.; Hausenloy, D.J. Myocardial reperfusion injury. N. Engl. J. Med. 2007, 357, 1121–1135. [CrossRef] [PubMed]
Turer, A.T.; Hill, J.A. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am. J. Cardiol.
2010, 106, 360–368. [CrossRef] [PubMed]
Kloner, R.A.; Brown, D.A.; Csete, M.; Dai, W.; Downey, J.M.; Gottlieb, R.A.; Hale, S.L.; Shi, J. New and revisited approaches to
preserving the reperfused myocardium. Nat. Rev. Cardiol. 2017, 14, 679–693. [CrossRef] [PubMed]
Schwartz Longacre, L.; Kloner, R.A.; Arai, A.E.; Baines, C.P.; Bolli, R.; Braunwald, E.; Downey, J.; Gibbons, R.J.; Gottlieb, R.A.;
Heusch, G.; et al. New horizons in cardioprotection: Recommendations from the 2010 National Heart, Lung, and Blood Institute
Workshop. Circulation 2011, 124, 1172–1179. [CrossRef]
Frohlich, G.M.; Meier, P.; White, S.K.; Yellon, D.M.; Hausenloy, D.J. Myocardial reperfusion injury: Looking beyond primary PCI.
Eur. Heart J. 2013, 34, 1714–1722. [CrossRef]
Xie, M.; Kong, Y.; Tan, W.; May, H.; Battiprolu, P.K.; Pedrozo, Z.; Wang, Z.V.; Morales, C.; Luo, X.; Cho, G.; et al. Histone
deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 2014, 129, 1139–1151.
[CrossRef]
Yang, J.; He, J.; Ismail, M.; Tweeten, S.; Zeng, F.; Gao, L.; Ballinger, S.; Young, M.; Prabhu, S.D.; Rowe, G.C.; et al. HDAC inhibition
induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion
injury. J. Mol. Cell Cardiol. 2019, 130, 36–48. [CrossRef]
McKinsey, T.A. The biology and therapeutic implications of HDACs in the heart. Handb. Exp. Pharmacol. 2011, 206, 57–78.
[CrossRef]

Cells 2022, 11, 2111

9.
10.
11.
12.
13.

14.

15.
16.

17.
18.
19.
20.
21.
22.

23.

24.
25.
26.

27.
28.

29.
30.

31.
32.
33.

19 of 21

Shoji-Kawata, S.; Sumpter, R.; Leveno, M.; Campbell, G.R.; Zou, Z.; Kinch, L.; Wilkins, A.D.; Sun, Q.; Pallauf, K.; MacDuff, D.;
et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 2013, 494, 201–206. [CrossRef]
Xie, M.; Cho, G.W.; Kong, Y.; Li, D.L.; Altamirano, F.; Luo, X.; Morales, C.R.; Jiang, N.; Schiattarella, G.G.; May, H.I.; et al.
Activation of Autophagic Flux Blunts Cardiac Ischemia/Reperfusion Injury. Circ. Res. 2021, 129, 435–450. [CrossRef]
Ju, J.S.; Jeon, S.I.; Park, J.Y.; Lee, J.Y.; Lee, S.C.; Cho, K.J.; Jeong, J.M. Autophagy plays a role in skeletal muscle mitochondrial
biogenesis in an endurance exercise-trained condition. J. Physiol. Sci. 2016, 66, 417–430. [CrossRef] [PubMed]
McKinsey, T.A. Therapeutic potential for HDAC inhibitors in the heart. Annu. Rev. Pharmacol. Toxicol. 2012, 52, 303–319.
[CrossRef] [PubMed]
Morales, C.R.; Li, D.L.; Pedrozo, Z.; May, H.I.; Jiang, N.; Kyrychenko, V.; Cho, G.W.; Kim, S.Y.; Wang, Z.V.; Rotter, D.; et al.
Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression. Sci. Signal.
2016, 9, ra34. [CrossRef] [PubMed]
Herr, D.J.; Baarine, M.; Aune, S.E.; Li, X.; Ball, L.E.; Lemasters, J.J.; Beeson, C.C.; Chou, J.C.; Menick, D.R. HDAC1 localizes to the
mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. J. Mol. Cell Cardiol. 2018, 114, 309–319.
[CrossRef] [PubMed]
Komatsu, M.; Waguri, S.; Ueno, T.; Iwata, J.; Murata, S.; Tanida, I.; Ezaki, J.; Mizushima, N.; Ohsumi, Y.; Uchiyama, Y.; et al.
Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 2005, 169, 425–434. [CrossRef]
Sohal, D.S.; Nghiem, M.; Crackower, M.A.; Witt, S.A.; Kimball, T.R.; Tymitz, K.M.; Penninger, J.M.; Molkentin, J.D. Temporally
regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ.
Res. 2001, 89, 20–25. [CrossRef]
Louch, W.E.; Sheehan, K.A.; Wolska, B.M. Methods in cardiomyocyte isolation, culture, and gene transfer. J. Mol. Cell Cardiol.
2011, 51, 288–298. [CrossRef]
Li, D.; Wu, J.; Bai, Y.; Zhao, X.; Liu, L. Isolation and culture of adult mouse cardiomyocytes for cell signaling and in vitro cardiac
hypertrophy. J. Vis. Exp. 2014, 87, e51357. [CrossRef]
Yitzhaki, S.; Huang, C.; Liu, W.; Lee, Y.; Gustafsson, A.B.; Mentzer, R.M., Jr.; Gottlieb, R.A. Autophagy is required for preconditioning by the adenosine A1 receptor-selective agonist CCPA. Basic Res. Cardiol. 2009, 104, 157–167. [CrossRef]
Ballinger, S.W.; Patterson, C.; Knight-Lozano, C.A.; Burow, D.L.; Conklin, C.A.; Hu, Z.; Reuf, J.; Horaist, C.; Lebovitz, R.; Hunter,
G.C.; et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106, 544–549. [CrossRef]
Yang, N.C.; Ho, W.M.; Chen, Y.H.; Hu, M.L. A convenient one-step extraction of cellular ATP using boiling water for the
luciferin-luciferase assay of ATP. Anal. Biochem. 2002, 306, 323–327. [CrossRef] [PubMed]
Dranka, B.P.; Benavides, G.A.; Diers, A.R.; Giordano, S.; Zelickson, B.R.; Reily, C.; Zou, L.; Chatham, J.C.; Hill, B.G.; Zhang, J.; et al.
Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic. Biol. Med. 2011, 51, 1621–1635.
[CrossRef] [PubMed]
Redmann, M.; Benavides, G.A.; Wani, W.Y.; Berryhill, T.F.; Ouyang, X.; Johnson, M.S.; Ravi, S.; Mitra, K.; Barnes, S.; Darley-Usmar,
V.M.; et al. Methods for assessing mitochondrial quality control mechanisms and cellular consequences in cell culture. Redox Biol.
2018, 17, 59–69. [CrossRef] [PubMed]
Xie, M.; Morales, C.R.; Lavandero, S.; Hill, J.A. Tuning flux: Autophagy as a target of heart disease therapy. Curr. Opin. Cardiol.
2011, 26, 216–222. [CrossRef]
Zheng, Y.; Gu, S.; Li, X.; Tan, J.; Liu, S.; Jiang, Y.; Zhang, C.; Gao, L.; Yang, H.-T. Berbamine postconditioning protects the heart
from ischemia/reperfusion injury through modulation of autophagy. Cell Death Dis. 2017, 8, e2577. [CrossRef]
Song, H.; Yan, C.; Tian, X.; Zhu, N.; Li, Y.; Liu, D.; Liu, Y.; Liu, M.; Peng, C.; Zhang, Q.; et al. CREG protects from myocardial
ischemia/reperfusion injury by regulating myocardial autophagy and apoptosis. Biochim. Biophys. Acta Mol. Basis Dis.
2017, 1863, 1893–1903. [CrossRef]
Murphy, E.; Steenbergen, C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev.
2008, 88, 581–609. [CrossRef]
Hendgen-Cotta, U.B.; Merx, M.W.; Shiva, S.; Schmitz, J.; Becher, S.; Klare, J.P.; Steinhoff, H.J.; Goedecke, A.; Schrader, J.; Gladwin,
M.T.; et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion
injury. Proc. Natl. Acad. Sci. USA 2008, 105, 10256–10261. [CrossRef]
Lee, M.S. Role of mitochondrial function in cell death and body metabolism. Front. Biosci. (Landmark Ed.) 2016, 21, 1233–1244.
Nazari, A.; Sadr, S.S.; Faghihi, M.; Azizi, Y.; Hosseini, M.J.; Mobarra, N.; Tavakoli, A.; Imani, A. Vasopressin attenuates ischemiareperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat
hearts. Eur. J. Pharmacol. 2015, 760, 96–102. [CrossRef]
Saito, T.; Sadoshima, J. Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ. Res.
2015, 116, 1477–1490. [CrossRef] [PubMed]
Hill, B.G.; Dranka, B.P.; Zou, L.; Chatham, J.C.; Darley-Usmar, V.M. Importance of the bioenergetic reserve capacity in response to
cardiomyocyte stress induced by 4-hydroxynonenal. Biochem. J. 2009, 424, 99–107. [CrossRef] [PubMed]
Sakamuri, S.; Sperling, J.A.; Sure, V.N.; Dholakia, M.H.; Peterson, N.R.; Rutkai, I.; Mahalingam, P.S.; Satou, R.; Katakam, P.V.G.
Measurement of respiratory function in isolated cardiac mitochondria using Seahorse XFe24 Analyzer: Applications for aging
research. Geroscience 2018, 40, 347–356. [CrossRef] [PubMed]

Cells 2022, 11, 2111

34.
35.
36.
37.

38.
39.
40.
41.
42.
43.
44.
45.
46.

47.

48.
49.
50.
51.
52.

53.
54.
55.
56.
57.

58.

59.
60.

20 of 21

Dorn, G.W., 2nd; Vega, R.B.; Kelly, D.P. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev.
2015, 29, 1981–1991. [CrossRef]
Vainshtein, A.; Tryon, L.D.; Pauly, M.; Hood, D.A. Role of PGC-1α during acute exercise-induced autophagy and mitophagy in
skeletal muscle. Am. J. Physiol. Cell Physiol. 2015, 308, C710–C719. [CrossRef]
Halling, J.F.; Ringholm, S.; Nielsen, M.M.; Overby, P.; Pilegaard, H. PGC-1α promotes exercise-induced autophagy in mouse
skeletal muscle. Physiol. Rep. 2016, 4, e12698. [CrossRef]
Grootaert, M.O.; da Costa Martins, P.A.; Bitsch, N.; Pintelon, I.; De Meyer, G.R.; Martinet, W.; Schrijvers, D.M. Defective autophagy
in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis. Autophagy
2015, 11, 2014–2032. [CrossRef]
Shin, J.H.; Ko, H.S.; Kang, H.; Lee, Y.; Lee, Y.I.; Pletinkova, O.; Troconso, J.C.; Dawson, V.L.; Dawson, T.M. PARIS (ZNF746)
repression of PGC-1alpha contributes to neurodegeneration in Parkinson’s disease. Cell 2011, 144, 689–702. [CrossRef]
Hausenloy, D.J.; Yellon, D.M. Myocardial ischemia-reperfusion injury: A neglected therapeutic target. J. Clin. Investig.
2013, 123, 92–100. [CrossRef]
Xue, R.Q.; Xu, M.; Yu, X.J.; Liu, L.Z.; Zang, W.J. Recent progress of mitochondrial quality control in ischemic heart disease and its
role in cardio-protection of vagal nerve. Acta Physiol. Sin. 2017, 69, 579–586.
Bliksoen, M.; Baysa, A.; Eide, L.; Bjoras, M.; Suganthan, R.; Vaage, J.; Stenslokken, K.O.; Valen, G. Mitochondrial DNA damage
and repair during ischemia-reperfusion injury of the heart. J. Mol. Cell Cardiol. 2015, 78, 9–22. [CrossRef]
Valero, T. Mitochondrial biogenesis: Pharmacological approaches. Curr. Pharm. Des. 2014, 20, 5507–5509. [CrossRef]
Onyango, I.G.; Lu, J.; Rodova, M.; Lezi, E.; Crafter, A.B.; Swerdlow, R.H. Regulation of neuron mitochondrial biogenesis and
relevance to brain health. Biochim. Biophys. Acta 2010, 1802, 228–234. [CrossRef]
Lee, H.C.; Wei, Y.H. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress.
Int. J. Biochem. Cell Biol. 2005, 37, 822–834. [CrossRef]
Song, M.; Franco, A.; Fleischer, J.A.; Zhang, L.; Dorn, G.W., 2nd. Abrogating Mitochondrial Dynamics in Mouse Hearts Accelerates
Mitochondrial Senescence. Cell Metab. 2017, 26, 872–883. [CrossRef]
Stevens, D.A.; Lee, Y.; Kang, H.C.; Lee, B.D.; Lee, Y.I.; Bower, A.; Jiang, H.; Kang, S.U.; Andrabi, S.A.; Dawson, V.L.; et al. Parkin
loss leads to PARIS-dependent declines in mitochondrial mass and respiration. Proc. Natl. Acad. Sci. USA 2015, 112, 11696–11701.
[CrossRef]
Tao, L.; Bei, Y.; Lin, S.; Zhang, H.; Zhou, Y.; Jiang, J.; Chen, P.; Shen, S.; Xiao, J.; Li, X. Exercise Training Protects Against
Acute Myocardial Infarction via Improving Myocardial Energy Metabolism and Mitochondrial Biogenesis. Cell Physiol. Biochem.
2015, 37, 162–175. [CrossRef]
Ma, X.; Liu, H.; Foyil, S.R.; Godar, R.J.; Weinheimer, C.J.; Diwan, A. Autophagy is impaired in cardiac ischemia-reperfusion injury.
Autophagy 2012, 8, 1394–1396. [CrossRef]
Zhang, J.; Nadtochiy, S.M.; Urciuoli, W.R.; Brookes, P.S. The cardioprotective compound cloxyquin uncouples mitochondria and
induces autophagy. Am. J. Physiol. Heart Circ. Physiol. 2016, 310, H29–H38. [CrossRef]
Di Lisa, F.; Bernardi, P. Modulation of Mitochondrial Permeability Transition in Ischemia-Reperfusion Injury of the Heart.
Advantages and Limitations. Curr. Med. Chem. 2015, 22, 2480–2487. [CrossRef]
Dutta, D.; Xu, J.; Kim, J.S.; Dunn, W.A., Jr.; Leeuwenburgh, C. Upregulated autophagy protects cardiomyocytes from oxidative
stress-induced toxicity. Autophagy 2013, 9, 328–344. [CrossRef]
Chouchani, E.T.; Methner, C.; Nadtochiy, S.M.; Logan, A.; Pell, V.R.; Ding, S.; James, A.M.; Cocheme, H.M.; Reinhold, J.; Lilley,
K.S.; et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat. Med. 2013, 19, 753–759.
[CrossRef]
Chinda, K.; Sanit, J.; Chattipakorn, S.; Chattipakorn, N. Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac
function via mitochondrial protection in ischaemia-reperfusion rat heart. Diab. Vasc. Dis. Res. 2014, 11, 75–83. [CrossRef]
Andres, A.M.; Hernandez, G.; Lee, P.; Huang, C.; Ratliff, E.P.; Sin, J.; Thornton, C.A.; Damasco, M.V.; Gottlieb, R.A. Mitophagy is
required for acute cardioprotection by simvastatin. Antioxid. Redox Signal. 2014, 21, 1960–1973. [CrossRef]
Delbridge, L.M.; Mellor, K.M.; Taylor, D.J.; Gottlieb, R.A. Myocardial autophagic energy stress responses–macroautophagy,
mitophagy, and glycophagy. Am. J. Physiol. Heart Circ. Physiol. 2015, 308, H1194–H1204. [CrossRef]
Scarffe, L.A.; Stevens, D.A.; Dawson, V.L.; Dawson, T.M. Parkin and PINK1: Much more than mitophagy. Trends Neurosci.
2014, 37, 315–324. [CrossRef]
Chouchani, E.T.; Pell, V.R.; Gaude, E.; Aksentijevic, D.; Sundier, S.Y.; Robb, E.L.; Logan, A.; Nadtochiy, S.M.; Ord, E.N.J.; Smith,
A.C.; et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014, 515, 431–435.
[CrossRef]
Murphy, E.; Ardehali, H.; Balaban, R.S.; DiLisa, F.; Dorn, G.W., 2nd; Kitsis, R.N.; Otsu, K.; Ping, P.; Rizzuto, R.; Sack, M.N.; et al.
Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association. Circ. Res.
2016, 118, 1960–1991. [CrossRef]
Schiattarella, G.G.; Hill, J.A. Therapeutic targeting of autophagy in cardiovascular disease. J. Mol. Cell Cardiol. 2016, 95, 86–93.
[CrossRef]
Zhang, Q.; Wu, Y.; Zhang, P.; Sha, H.; Jia, J.; Hu, Y.; Zhu, J. Exercise induces mitochondrial biogenesis after brain ischemia in rats.
Neuroscience 2012, 205, 10–17. [CrossRef]

Cells 2022, 11, 2111

61.
62.
63.

21 of 21

Funk, J.A.; Schnellmann, R.G. Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1alpha
activation following ischemia-reperfusion injury. Toxicol. Appl. Pharmacol. 2013, 273, 345–354. [CrossRef]
Chen, S.D.; Yang, D.I.; Lin, T.K.; Shaw, F.Z.; Liou, C.W.; Chuang, Y.C. Roles of oxidative stress, apoptosis, PGC-1alpha and
mitochondrial biogenesis in cerebral ischemia. Int. J. Mol. Sci. 2011, 12, 7199–7215. [CrossRef]
Li, Z.; Zhang, Q.; Pires, K.; Abel, E.D. Abstract 12606: Autophagy is Required for Mitochondrial Biogenesis in the Heart.
Circulation 2014, 130, A12606. [CrossRef]

